DALIRESP Reviews (ROFLUMILAST)Average Rating: 1.5 (2 Ratings)Filter ResultsCompare DALIRESP with similar:
Type: Rx Drug
|
Results are sorted by Date added. Key to Ratings: 1=LOW (I would not recommend taking this medicine.) Page: 1 |
RATING | REASON | SIDE EFFECTS FOR DALIRESP | COMMENTS | SEX | AGE | DURATION/ DOSAGE | DATE ADDED |
1 | copd | My husband has been taking this for 5-6 weeks, and it seems to me his breathing has gotten worse, and he is not sleeping well, at all. | F | 58 | 6 weeks 1X day | 12/10/2012 | 2 | copd | 500mg 1X day | 10/26/2012 |
DALIRESP (ROFLUMILAST): Roflumilast is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis). It should be used along with other medications (bronchodilators such as salmeterol, ipratropium) to treat COPD. It works by reducing the irritation and swelling of the airways. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. FDA Approval Date: 2011-02-28 (Sources: U.S. Centers for Medicare Services, FDA)